Two Novel SCN9A Gene Heterozygous Mutations May Cause Partial Deletion of Pain Perception

Pain Medicine

Volumn 12, Issue 10, 2011, Pages 1510-1514

  Yuan, Ruimei ^a   Zhang, Xianwei ^a   Deng, Qian ^a   Si, Dayong ^b   Wu, Yuan ^a   Gao, Feng ^a   Zhou, Biyun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Anesthesia; CIP; Mutation; Nav1.7; Pain; SCN9A

Indexed keywords

AMINO ACID; FENTANYL; MIDAZOLAM; PROPOFOL; SODIUM CHANNEL NAV1.7;

AMINO ACID SUBSTITUTION; ANKLE; ARTICLE; AUTONOMIC NEUROPATHY; BONE NECROSIS; CASE REPORT; CHILD; CHINESE; CONGENITAL ANALGESIA; COXITIS; DAILY LIFE ACTIVITY; FEMALE; FEMUR FRACTURE; FEMUR HEAD; FOREFOOT; FRACTURE; FRACTURE EXTERNAL FIXATION; GENE MUTATION; HETEROZYGOSITY; HIP DISLOCATION; HUMAN; INTRAVENOUS ANESTHESIA; LEG FRACTURE; LIP; MALE; MOUTH INJURY; MUTATIONAL ANALYSIS; NOCICEPTION; OSTEOARTHRITIS; PAIN ASSESSMENT; PAIN THRESHOLD; POSTOPERATIVE PAIN; SCHOOL CHILD; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN BRUISING; TALUS; TIBIA FRACTURE; TONGUE;

EID: 80255129735     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01237.x     Document Type: Article

References (22)

1. Nassar MA, Stirling LC, Forlani G, etal. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc Natl Acad Sci U S A 2004;101:12706-11.
2. Cox JJ, Reimann F, Nicholas AK, etal. An SCN9A channelopathy causes ccongenital inability to experience pain. Nature 2006;444:894-8.
3. Akopian AN, Souslova V, England S, etal. The tetrodotoxin-resistant sodium' channel SNS has a specialized function in pain pathways. Nat Neurosci 1999;2:541-8.
4. Nassar MA, Levato A, Stirling LC, Wood JN. Neuropathic pain develops normally in mice lacking both Na(v)1.7 and Na(v)1.8. Mol Pain 2005;1:24.
5. Young FB. A life without pain? Hedonists take note. Clin Genet 2008;73:31-3.
6. Ahmad S, Dahllund L, Eriksson AB, etal. A stop codon mutation in SCN9A causes lack of pain sensation. Hum Mol Genet 2007;16:2114-21.
7. Yang Y, Wang Y, Li S, etal. Mutations in SCN9A, encoding a sodium channel a subunit, in patients with primary erythermalgia. J Med Genet 2004;41:171-4.
8. Estacion M, Harty TP, Choi JS, etal. A sodium channel gene SCN9A polymorphism that increases nociceptor excitability. Ann Neurol 2009;66:862-6.
9. Dib-Hajj SD, Estacion M, Jarecki BW, etal. Paroxysmal extreme pain disorder M1627K mutation in human Nav1.7 renders DRG neurons hyperexcitable. Mol Pain 2008;4:37.
10. Cheng X, Dib-Hajj SD, Tyrrell L, Waxman SG. Mutation I136V alters electrophysiological properties of the NaV1.7 channel in a family with onset of erythromelalgia in the second decade. Mol Pain 2008;4:1.
11. Fertleman CR, Baker MD, Parker KA, etal. SCN9A mutations in paroxysmal extreme pain disorder: Allelic variants underlie distinct channel defects and phenotypes. Neuron 2006;52:767-74.
12. Drenth JP, te Morsche RH, Guillet G, etal. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol 2005;124:1333-8.
13. Wang Y, Yang Y, Li S, etal. Gene mapping and mutation indentification in patients with primary erythromelalgia. Chin J Dermatol 2004;37:383-6.
14. Klugbauer N, Lacinova L, Flockerzi V, Hofmann F. Structure and functional expression of a new member of the tetrodotoxin-sensitive voltage-activated sodium channel family from human neuroendocrine cells. EMBO J 1995;14:1084-90.
15. Toledo-Aral JJ, Moss BL, He ZJ, etal. Identification of PN1, a predominant voltage-dependent sodium channel expressed principally in peripheral neurons. Proc Natl Acad Sci U S A 1997;94:1527-32.
16. Cummins TR, Dib-Hajj SD, Waxman SG. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J Neurosci 2004;24:8232-6.
17. Dib-Hajj SD, Rush AM, Cummins TR, etal. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 2005;128:1847-54.
18. Han C, Rush AM, Dib-Hajj SD, etal. Sporadic onset of erythermalgia: A gain-of-function mutation in Nav1.7. Ann Neurol 2006;59:553-8.
19. Goldberg YP, MacFarlane J, MacDonald ML, etal. Loss-of-function mutations in the Nav1.7 gene underlie congenital indifference to pain in multiple human populations. Clin Genet 2007;71:311-9.
20. Waxman SG. Neurobiology: A channel sets the gain on pain. Nature 2006;444:831-2.
21. Reimann F, Cox JJ, Belfer I, etal. Pain perception is altered by a nucleotide polymorphism in SCN9A. Proc Natl Acad Sci U S A 2010;107:5148-53.
22. Dyck PJ. Peripheral Neuropathy. Philadelphia, PA: WB Saunders; 1984:1557-99.